Atripla to Raltegravir Switch Study for CNS Toxicity
NCT01195467
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
Truvada/Raltegravir
Sponsor
St Stephens Aids Trust